Blood Glucose Control

Man, 52 years of age, type 2 diabetes, obesity class II on Victoza. He was very pleased with treatment response, lowering glucose levels, feeling full and more satisfied, but having a skin reaction.

In this week's Homerun Slides, the results of lowering plasma glucose concentration with dapagliflozin.

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. In this final installment, Dr. Hirsch summarizes his ADA 2015 presentation, including a comparison of the BD infusion set to the current popular model, and images showing the fluid within infusion sets as captured by MRI and ultrasound.

Very elevated HbA1c associated with fasting blood glucose levels.

Appropriate intensification and deintensification in medication use may be of benefit.

Male, 72 years of age, type 2 diabetes, overweight secondary to binge eating disorder. Taking glipizide 20mg daily and metformin 1,000mg twice daily. Hypoglycemic unawareness. Not regularly checking glucose. Recent A1C 6.8%.

This is an update from a 2008 recommendation that only mentioned hypertension.

New study suggests that in hospital patients with T2DM, premixed insulin provides similar glycemic control as a basal-bolus insulin regimen.

I asked a patient with erratic glucose levels where he usually gave his insulin injections to which he responded, "In my arms." I asked, "Could you show me where?" The patient promptly rolled up his sleeves and pointed to the vein in his antecubital space.

The FDA is requiring the drug company to submit more clinical data.